We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers Sued by FTC for “Pay-to-Delay” With AndroGel
Drugmakers Sued by FTC for “Pay-to-Delay” With AndroGel
February 6, 2009
The FTC and the state of California are suing four drugmakers, contending they delayed the introduction of generic versions of Solvay Pharmaceuticals’ AndroGel testosterone-replacement drug.